What is included in the FDA’s June 2026 list of off-patent drugs without generics?

In June 2026, the FDA released its updated List of Off-Patent, Off-Exclusivity Drugs without an Approved Generic, covering both prescription and OTC products. The list identifies drugs eligible for generic development, those facing complexities, and those recently removed after ANDA approval, offering a snapshot of current generic market gaps.